CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 217 filers reported holding CHEMOCENTRYX INC in Q3 2022. The put-call ratio across all filers is 0.77 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $138,000 | +109.1% | 2,681 | -0.4% | 0.00% | – |
| Q2 2022 | $66,000 | -23.3% | 2,693 | -21.4% | 0.00% | – |
| Q1 2022 | $86,000 | -24.6% | 3,425 | +9.3% | 0.00% | – |
| Q4 2021 | $114,000 | +115.1% | 3,134 | +1.7% | 0.00% | – |
| Q3 2021 | $53,000 | +103.8% | 3,083 | +57.1% | 0.00% | – |
| Q2 2021 | $26,000 | -91.8% | 1,962 | -68.4% | 0.00% | -100.0% |
| Q1 2021 | $318,000 | -21.5% | 6,215 | -5.0% | 0.00% | 0.0% |
| Q4 2020 | $405,000 | +128.8% | 6,542 | +102.2% | 0.00% | – |
| Q3 2020 | $177,000 | – | 3,236 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 7,796,516 | $45,142,000 | 7.90% |
| GREAT POINT PARTNERS LLC | 1,000,000 | $5,790,000 | 4.09% |
| Belmont Global Advisors, Inc. | 175,000 | $1,013,000 | 0.82% |
| Broadfin Capital, LLC | 1,033,668 | $5,985,000 | 0.79% |
| WASATCH ADVISORS LP | 2,650,551 | $15,347,000 | 0.15% |
| BALYASNY ASSET MANAGEMENT L.P. | 1,158,613 | $6,708,000 | 0.09% |
| Artal Group S.A. | 275,000 | $1,592,000 | 0.06% |
| STONERIDGE INVESTMENT PARTNERS LLC | 41,355 | $239,000 | 0.05% |
| A.R.T. Advisors, LLC | 33,501 | $193,000 | 0.01% |
| BANQUE PICTET & CIE SA | 50,932 | $295,000 | 0.01% |